SCHEDULE 13D/AAccepted May 14, 5:52 PM ET
BridgeBio Pharma, Inc. SCHEDULE 13D/A
Accepted (ET)
5:52 PM
May 14, 2025
Filed
May 14, 2025
Documents
2
Size
24.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.